# Jord BioScience

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/jord-bioscience

- Industry: Biotechnology
- Headquarters: St. Paul, US
- Website: www.jordbioscience.com
- Total disclosed funding: $7M
- Latest round: Series B (Feb 19, 2025)
- Investors on record: 2

## About

Biocontrol, LLC doing business as Jord BioScience, develops innovative microbial solutions to enhance agricultural productivity and sustainability, focusing on optimizing soil health and improving crop yield through advanced biological products. Founded in 2020, Jord BioScience focuses on developing microbial solutions for agriculture. In February 2025, Jord BioScience raised USD 7 million in Series B funding led by Silver Blue LLC, with participation from Discovery Capital, and Minnesota Small Business Credit Initiative. Jord BioScience specializes in the development of advanced microbial solutions aimed at enhancing agricultural productivity and sustainability. The company’s core product offerings include proprietary microbial inoculants designed to optimize soil microbiomes, protect crops from pathogens, and stimulate plant growth. These formulations are particularly effective when paired with existing commercial inoculants, as evidenced by reported performance improvements in key metrics such as phosphate and zinc solubilization. Jord’s technology has been validated across a range of major crop systems, including corn, soybean, wheat, and rice, targeting agricultural markets in North America and globally. The end users of these products encompass leading agricultural companies, farmers, and agronomists seeking to improve crop yields and overall plant health through innovative biological solutions. Jord BioScience's revenue is generated primarily through partnerships with agricultural companies that integrate its microbial solutions into their product offerings. Transactions typically occur in a B2B framework, where Jord collaborates with commercial partners to enhance existing agricultural products. The pricing structure for these collaborations is based on product performance metrics and the added value provided by Jord's technology, facilitating negotiations that align with the expected outcomes in crop performance and sustainability. The company’s flagship products, designed for widespread use in various agricultural applications, are positioned to support the increasing demand for biological solutions in agriculture, with revenue influenced by the partnerships formed and the scalability of their microbial formulations within the market. In February 2025, Jord BioScience raised USD 7.00 mn in Series B funding, which will be utilized to fast-track the development of biological solutions in agribusiness by leveraging its extensive microbial bank of over 6,500 microbial isolates. The company is actively working on launching new products designed to address emerging agricultural needs and is targeting expansion into new markets in North America and Europe by 2026.

## Funding rounds

- Series B, Feb 19, 2025, $7M — Discovery Capital, Silver Blue LLC

## Investors

- Discovery Capital (https://capitalatlas.ai/funds/discovery-capital) — Series B
- Silver Blue LLC — Series B